Italy versus the United Kingdom: Differing styles for treating bacteremia in the critically ill patient, but who's right?

Minerva Anestesiologica

Volumn 74, Issue 5, 2008, Pages 155-163

  Corona, A ^a,b   Cislaghi, F ^b   Raimondi, F ^b   Singer, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Anti bacterial agents; Bacteremia; Intensive case; Questionnaires

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; POLYENE ANTIBIOTIC AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CATHETER INFECTION; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION FUNCTION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; FUNGEMIA; GRAM NEGATIVE SEPSIS; HUMAN; INTENSIVE CARE UNIT; INTERDISCIPLINARY COMMUNICATION; ITALY; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MEDICAL SPECIALIST; MONOTHERAPY; PERITONITIS; PNEUMONIA; QUESTIONNAIRE; SHORT COURSE THERAPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CRITICAL ILLNESS; GREAT BRITAIN; HUMANS; INTENSIVE CARE UNITS; ITALY; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 46049094173     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hugonner S, Sax H, Eggimann P, Chevrolet JC, Pittet D. Nosocomial bloodstream infection and clinical sepsis. Emerg Infect Dis 2004;10:76-81.
2. Zaragoza R, Artero A, Camarena JJ, Sancho S, González R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003;9:412-8.
3. Vallés J, Rello J, Ochagavía A, Garnacho J, Alcalá MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003;123:1615-24.
4. Harbarth S, Ferrière K, Hugonnet S, Ricou B, Suter P, Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 2002;137:1353-9; discussion 1359.
5. Renaud B, Brun-Buisson C; ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001;163:1584-90.
6. Sligl W, Taylor G, Brindley PG. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006;10:320-5.
7. Suljagiç V, Cobeljiç M, Jankoviç S, Miroviç V, Markoviç-Deniç L, Romiç P et al. Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control 2005;33:333-40.
8. Corona A, Wilson AP, Grassi M, Singer M. Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy. J Antimicrob Chemother 2004;54:809-17.
9. Nicastri E, Petrosillo N, Martini L, Larosa M, Gesu GP, Ippolito G; INF-NOS Study Group. Prevalence of nosocomial infections in 15 Italian hospitals: first point prevalance study for the INF-NOS project. Infection 2003;31(Suppl 2):10-5.
10. Edgeworth JD, Treacher DF, Eykyn SJ. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999;27:1421-8.
11. Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis 1997;24:387-95.
12. Pittet D, Thievent B, Wenzel RP, Li N, Auckenthaler R, Suter PM. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996;153:684-93.
13. Rello J, Ricart M, Mirelis B, Quintana E, Gurgui M, Net A et al. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 1994;20:94-8.
14. Laupland KB, Zygun DA, Doig CJ, Bagshaw SM, Svenson LW, Fick GH. One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system. Intensive Care Med 2005;31:213-9.
15. Kim PW, Perl TM, Keelaghan EF, Langenberg P, Perencevich EN, Harris AD et al. Risk of mortality with a bloodstream infection is higher in the less severely ill at admission. Am J Respit Crit Care Med 2005;171:616-20.
16. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-601.
17. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146-55.
18. McGowan JE. Strategies for study of the role of cycling on antimicrobial use and resistance. Infect Control Hosp Epidemiol 2000;21(Suppl 1):S36-43.
19. Mouton JW. Combination therapy as a tool to prevent emergence of bacterial resistance. Infection 1999;27 (Suppl 2): S24-8. 22.
20. Elliott TSJ, Lambert HA. Antibacterial resistance in the intensive care unit: mechanism and management. Br Med Bull 1999;55:259-76.
21. Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996;38:409-24.
22. Isaacs D, Fitzgerald D. Seven alternatives to evidence based medicine. BMJ 1999;319:1618.